Meeting highlights. Highlights of the 48th scientific sessions of the American College of Cardiology.
Ferguson
J J
JJ
D000077284:Abciximab; D000409:Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001550:Benzamidines / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002309:Cardiology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D017985:Dalteparin / Q000627:therapeutic use; D017147:Defibrillators, Implantable; D004311:Double-Blind Method; D004656:Enalapril / Q000627:therapeutic use; D016228:Endothelial Growth Factors / Q000627:therapeutic use; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D053685:Laser Therapy; D008222:Lymphokines / Q000627:therapeutic use; D008790:Metoprolol / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009204:Myocardial Revascularization; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D019821:Simvastatin / Q000627:therapeutic use; D017923:Sodium-Hydrogen Exchangers / Q000037:antagonists & inhibitors; D015607:Stents; D013450:Sulfones / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D014810:Vitamin E / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000911:Antibodies, Monoclonal; D001550:Benzamidines; D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D016228:Endothelial Growth Factors; D015525:Fatty Acids, Omega-3; D006146:Guanidines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007140:Immunoglobulin Fab Fragments; D008222:Lymphokines; D010975:Platelet Aggregation Inhibitors; D011759:Pyrrolidines; D017923:Sodium-Hydrogen Exchangers; D013450:Sulfones; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C107918:lefradafiban; D014810:Vitamin E; C081981:lanoteplase; D004656:Enalapril; C093373:cariporide; D000077144:Clopidogrel; D019821:Simvastatin; D010959:Tissue Plasminogen Activator; C120234:orbofiban; D008790:Metoprolol; D000409:Alanine; D013988:Ticlopidine; C091295:xemilofiban; D001241:Aspirin; D017985:Dalteparin; D000077284:Abciximab